Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine M Behrens

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Obstetrics and Gynecology|January 23, 2015
In replyWarner K Huh, Catherine M Behrens
American Journal of Clinical Pathology|August 21, 2016
Knowledge of Patients' Human Papillomavirus Status at the Time of Cytologic Review Significantly Affects the Performance of Cervical Cytology in the ATHENA StudyThomas C Wright, Mark H Stoler, Shagufta Aslam, et al.
The Journal of Molecular Diagnostics : JMD|January 3, 2017
Development and Validation of a Preanalytic Procedure for Performing the cobas HPV Test in SurePath Preservative FluidMark D Krevolin, David Hardy, Jim Pane, et al.
American Journal of Clinical Pathology|October 19, 2017
Performance of the cobas HPV Test for the Triage of Atypical Squamous Cells of Undetermined Significance Cytology in Cervical Specimens Collected in SurePathDevansu Tewari, Susan Novak-Weekley, Christina Hong, et al.
Obstetrics and Gynecology|September 9, 2014
Relevance of random biopsy at the transformation zone when colposcopy is negativeWarner K Huh, Mario Sideri, Mark Stoler, et al.
International Journal of Cancer|October 15, 2013
Interlaboratory variation in the performance of liquid-based cytology: insights from the ATHENA trialThomas C Wright, Mark H Stoler, Catherine M Behrens, et al.
American Journal of Obstetrics and Gynecology|November 24, 2012
Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV studyJ Thomas Cox, Phillip E Castle, Catherine M Behrens, et al.
American Journal of Obstetrics and Gynecology|September 28, 2011
The ATHENA human papillomavirus study: design, methods, and baseline resultsThomas C Wright, Mark H Stoler, Catherine M Behrens, et al.
Gynecologic Oncology|January 13, 2015
Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening testThomas C Wright, Mark H Stoler, Catherine M Behrens, et al.
Cancer Cytopathology|June 22, 2012
Comparison of cobas human papillomavirus test results from primary versus secondary vials of PreservCyt specimens and evaluation of potential cross-contaminationArundhati Rao, Stephen Young, Mark Krevolin, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Obstetrics and Gynecology|January 23, 2015
In replyWarner K Huh, Catherine M Behrens
American Journal of Clinical Pathology|August 21, 2016
Knowledge of Patients' Human Papillomavirus Status at the Time of Cytologic Review Significantly Affects the Performance of Cervical Cytology in the ATHENA StudyThomas C Wright, Mark H Stoler, Shagufta Aslam, et al.
The Journal of Molecular Diagnostics : JMD|January 3, 2017
Development and Validation of a Preanalytic Procedure for Performing the cobas HPV Test in SurePath Preservative FluidMark D Krevolin, David Hardy, Jim Pane, et al.
American Journal of Clinical Pathology|October 19, 2017
Performance of the cobas HPV Test for the Triage of Atypical Squamous Cells of Undetermined Significance Cytology in Cervical Specimens Collected in SurePathDevansu Tewari, Susan Novak-Weekley, Christina Hong, et al.
Obstetrics and Gynecology|September 9, 2014
Relevance of random biopsy at the transformation zone when colposcopy is negativeWarner K Huh, Mario Sideri, Mark Stoler, et al.
International Journal of Cancer|October 15, 2013
Interlaboratory variation in the performance of liquid-based cytology: insights from the ATHENA trialThomas C Wright, Mark H Stoler, Catherine M Behrens, et al.
American Journal of Obstetrics and Gynecology|November 24, 2012
Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV studyJ Thomas Cox, Phillip E Castle, Catherine M Behrens, et al.
American Journal of Obstetrics and Gynecology|September 28, 2011
The ATHENA human papillomavirus study: design, methods, and baseline resultsThomas C Wright, Mark H Stoler, Catherine M Behrens, et al.
Gynecologic Oncology|January 13, 2015
Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening testThomas C Wright, Mark H Stoler, Catherine M Behrens, et al.
Cancer Cytopathology|June 22, 2012
Comparison of cobas human papillomavirus test results from primary versus secondary vials of PreservCyt specimens and evaluation of potential cross-contaminationArundhati Rao, Stephen Young, Mark Krevolin, et al.
Pageof 2